Director – Portfolio Valuation & Decision Analysis Job Jacksonville area,Florida USA,Finance & Banking

Mylan Inc. Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases.

We have been included on number of award lists that demonstrate the impact we are making. Every day, we rise to the challenge to make a difference and here’s how the Director – Portfolio Valuation & Decision Analysis role will make an impact:

here’s how the Director – Portfolio Valuation & Decision Analysis role will make an impact:

Partner with Program Leaders and Managers, Global Portfolio Managers, Finance and Commercial and cross‑functional teams to evaluate development strategies, investment alternatives, and lifecycle opportunities.
Support stage‑gate reviews and governance decisions through objective assessments of program value, risk, and strategic considerations.
Provide program teams and decision makers with actionable recommendations to support program strategic planning, prioritization, and resource allocation.
Lead the development and ongoing assessment of program business cases and portfolio value.
Ensure business cases reflect current development plans, commercial assumptions, competitive dynamics, and investment requirements.
Proactively identify and communicate material changes in program value, risk, and investment outlook.
Support evaluation of external opportunities, including licensing, partnerships, and co‑development.
Lead scenario, sensitivity, and risk analyses to evaluate strategic alternatives and key value drivers.
Assess the impact of development, commercial, regulatory, and market uncertainties on program and portfolio value.
Deliver insights that support portfolio optimization, long‑range planning, and investment decision‑making.
Establish and maintain standards, methodologies, and governance processes for business case development and portfolio valuation.
Ensure consistent, transparent, and objective evaluation of programs and investment opportunities across the portfolio.
Drive alignment on key assumptions, decision criteria, and valuation approaches.

The minimum qualifications for this role are:

Bachelor's degree required in Business Analytics, Decision Sciences, Operations Research, Engineering or related discipline.
Preferred candidate will have a Master's degree (MBA, MS, or related advanced degree) preferred.
10+ years of experience in pharmaceutical, biotechnology, or life sciences organizations.
6+ years of experience in portfolio management, strategic planning, finance, commercial assessment, or decision analysis.
However, a combination of experience and/or education will be taken into consideration.
Demonstrated experience supporting stage‑gate reviews, portfolio prioritization, and strategic investment decisions.
Experience working with program teams and senior leadership to support program investment and resource planning decisions.
Deep understanding of pharmaceutical R&D, portfolio management, and product development.
Expertise in business case development, portfolio valuation, financial modeling (NPV), and scenario analysis.
Strong strategic thinking with the ability to evaluate investment opportunities, risks, and trade‑offs.
Ability to synthesize scientific, commercial, and financial inputs into clear recommendations for senior leadership.
Strong communication, influencing, and stakeholder management skills in a highly matrixed…